In the second of IBO’s biannual reviews of new analytical-instrument and laboratory-product patent litigation (see IBO 4/30/14), the focus is on settlements and dismissals. Among the long-running disputes that have been resolved are cases involving Agilent Technologies and Illumina. New Suits GE Bio-Science filed suit against Bio-Rad Laboratories in the US District Court for the […]
Washington, DC 9/30/14—In an SEC filing, Agilent Technologies announced that the US Department of Justice (DOJ) has closed its inquiry into possible violations of the US Foreign Corrupt Practices Act by the company’s employees in China (see IBO 9/15/13). Agilent was notified earlier this month that after completing its investigation, the SEC’s Division of Enforcement […]
San Diego, CA 7/28/14—Independent service organization (ISO) Zef Scientific has filed suit against Shimadzu Scientific Instruments (SSI) in US District Court for the Southern District of California, alleging monopolization, restraint of trade, tortious interference with contractual relations, tortious interference with prospective business advantage, and unfair competition. In the complaint, Zef states that SSI changed its […]
The US Patent and Trademark Office (PTO) has proposed new patent guidelines for natural products and processes, raising concern that the standard is too strict. The revised guidelines follow two Supreme Court decisions involving Prometheus Laboratories and Myriad Genetics that denied patents based on the patent code’s forbiddance of patenting “laws of nature, natural phenomena […]
New York, NY 4/23/14; New York, NY 4/24/24—Enzo Biochem has announced a settlement agreement with Affymetrix in two separate 2003 cases brought by the companies against each other. Under the settlement agreement, Affymetrix will pay Enzo $5.21 million. Enzo sued Affymetrix, alleging breach of a 1998 agreement (that was terminated in 2003) under which the […]
Settlements dominate this spring’s look at patent infringement litigation among instrument and lab product firms. New suits were filed targeting Luminex and microscopy companies. New Suits Last November, Irori Technologies, a supplier of combinatorial chemistry systems, filed suit in Southern California District Court against Luminex (see table). The complaint alleged infringement of three patents by […]
Washington, DC 3/18/14—Bio-Rad Laboratories reported in its annual 10K SEC filing for 2013 that it has identified a material weakness in its internal control over financial reporting. This follows the company’s identification of other material weaknesses in internal controls in 2011 and 2012 (see IBO 4/30/13). In its latest 10K filing, the company stated, “we […]
New York, NY 10/22/13; New York, NY 11/27/13; New York, NY 12/6/13; New York, NY 12/27/13—The District Court for the Southern District of New York has ruled in two suits brought by life science consumables firm Enzo Biochem. In October, the court granted Amersham’s motion for summary judgment, denying Enzo’s claims of fraudulent inducement, breach […]
Toulouse, France 12/10/13—Alpha MOS has confirmed to IBO that the company has filed for Chapter 11 protection in France. Describing the company’s plans following a court hearing, Alpha MOS President Jean Christophe Mifsud told IBO, “We have six months probation during which we are going to continue our focus on food safety and food quality, […]
In this issue, IBO presents its second of two articles this year detailing developments in patent infringement litigation involving instrument and lab product firms (see IBO 4/30/13). The pace of new litigation appears to have slowed. In addition, new settlements and rulings have put to rest, for now, some long running disputes. New Suits In […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
